Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study

BACKGROUND: The tyrosine kinase inhibitor pazopanib is used for treatment of sarcoma. Recent studies have suggested that the use of pazopanib may lead to the development of pneumothorax, an unexpected adverse effect in patients with sarcoma metastatic to the chest. METHODS: We conducted a retrospect...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:BMC Cancer
Main Authors: Sabath, Bruce, Muhammad, Hasan A, Balagani, Amulya, Ost, David E, Vakil, Erik, Ahmed, Tahreem, Vial, Macarena R, Grosu, Horiana B
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2018
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6167904/
https://ncbi.nlm.nih.gov/pubmed/30285733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4858-8
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker